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Structural basis of Sorcin-mediated 
calcium-dependent signal 
transduction
Andrea Ilari1, Annarita Fiorillo1, Elena Poser1, Vasiliki S. Lalioti2, Gustav N. Sundell3, 
Ylva Ivarsson3, Ilaria Genovese1 & Gianni Colotti1
Sorcin is an essential penta-EF hand calcium binding protein, able to confer the multi-drug resistance 
phenotype to drug-sensitive cancer cells and to reduce Endoplasmic Reticulum stress and cell 
death. Sorcin silencing blocks cell cycle progression in mitosis and induces cell death by triggering 
apoptosis. Sorcin participates in the modulation of calcium homeostasis and in calcium-dependent 
cell signalling in normal and cancer cells. The molecular basis of Sorcin action is yet unknown. The 
X-ray structures of Sorcin in the apo (apoSor) and in calcium bound form (CaSor) reveal the structural 
basis of Sorcin action: calcium binding to the EF1-3 hands promotes a large conformational change, 
involving a movement of the long D-helix joining the EF1-EF2 sub-domain to EF3 and the opening 
of EF1. This movement promotes the exposure of a hydrophobic pocket, which can accommodate 
in CaSor the portion of its N-terminal domain displaying the consensus binding motif identified by 
phage display experiments. This domain inhibits the interaction of sorcin with PDCD6, a protein that 
carries the Sorcin consensus motif, co-localizes with Sorcin in the perinuclear region of the cell and in 
the midbody and is involved in the onset of apoptosis.
Sorcin (Soluble resistance-related calcium binding protein) is a calcium binding oncoprotein expressed 
at high levels in several human tumours, such as leukaemia, gastric, breast and ovarian cancers1–5. Sorcin 
gene is located in chromosome 7, in the same amplicon of other proteins involved in MDR (multidrug 
resistance) such as ABCB4 and ABCB1 (Mdr1); Sorcin is highly expressed in different chemoresistant 
cell lines, and its overexpression confers MDR in several tumors6–11. Treatment with antisense oligonu-
cleotides increases cell sensitivity for vincristine and other antitumor drugs, suggesting that sorcin might 
be a useful marker of MDR and a therapeutic target for reversing tumor MDR12,13.
Sorcin is also considered one of the main regulators of calcium-induced calcium release in the 
heart4,14–18. Sorcin is one of the most expressed calcium-binding proteins in human cells, especially in 
the brain and in the heart (PaxDb). In particular Sorcin is one of the most expressed calcium binding 
proteins in the amygdala, in the prefrontal cortex, in the hypothalamus and in many brain cancers 
(GeneAtlas U133A, gcrma), such as anaplastic astrocytoma, oligodendroglioma, glioblastoma19–21, and is 
considered a histological marker for malignant glioma4.
The Sorcin mechanism of action is not fully understood. However, we have shown that Sorcin is an 
essential protein, which activates and regulates mitosis and cytokinesis22. Our analysis of the interactome 
of Sorcin revealed calcium-dependent interactions with kinases playing key roles in cell-cycle progres-
sion, including Polo-like kinase 1 that phosphorylates Sorcin. In addition, Sorcin silencing blocks cell 
cycle progression in mitosis and induces cell death. Sorcin localizes at the nucleus, endoplasmic reticulum 
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(ER) and cell membranes during interphase, while during mitosis, Sorcin concentrates in the cleavage 
furrow (late telophase) and midbody (cytokinesis). Upon calcium binding, Sorcin undergoes large con-
formational changes, presumably involving exposure of hydrophobic surfaces, that allows it to inter-
act with calcium channels, pumps and exchangers like ryanodine receptors (RyRs), sarco(endo)plasmic 
reticulum Ca2+ ATPase (SERCA), L-type voltage-dependent calcium channels and Na+-Ca2+ exchangers 
(NCX), and to regulate them14–17,23,24. Sorcin regulates calcium homeostasis by binding calcium, binding 
to and regulating the activity of calcium channels and other proteins; as a consequence, Sorcin increases 
Ca2+ accumulation in the endoplasmic (ER)/sarcoplasmic reticulum (SR) and mitochondria. Sorcin pre-
vents ER stress, and its silencing triggers apoptosis22,25,26. Knockdown of Sorcin in fact results in major 
defects in mitosis and cytokinesis, increase in the number of rounded polynucleated cells, blockage of cell 
progression in G2/M, apoptosis and cell death. ER stress is involved in the accumulation and deposits of 
misfolded proteins in many neurodegenerative diseases; Sorcin interacts in a calcium-dependent fashion 
with alpha-synuclein and presenilin 2, two proteins involved in the pathogenesis of Parkinson’s disease 
and Alzheimer’s disease, respectively, in vitro, in cultured cells and in human brain27,28.
From a structural point of view, Sorcin belongs to the small penta-EF-hand (PEF) family29. Each mon-
omer of Sorcin homodimer is formed by two domains, i.e. a flexible, glycine-rich N-terminal domain 
and a C-terminal calcium-binding domain (SCBD), endowed with five EF-hands30,31. The SCBD can be 
divided in two regions: EF1–3 (residues 33–134), which binds calcium with high affinity, and EF4–5 
(residues 135–198), which mediates dimerization. Upon calcium binding Sorcin undergoes a large con-
formational change that allows it to bind and regulate a series of target proteins in a calcium-dependent 
fashion32–34. However, the structural basis of its activation and of its ability to establish calcium-dependent 
interactions with targets is unclear. In addition, the peptide binding motifs are not known, despite the 
identification of several target proteins.
To investigate the structural basis of Sorcin activation and of selective calcium-dependent signal trans-
duction, we here solved the structure of the apo Sorcin (apoSor) and, for the first time, the structure of 
Sorcin in the calcium-bound form (CaSor). The structures have been compared with each other and with 
those of other PEF proteins evaluating: i) the internal variability of Sorcin; ii) the effect of the calcium 
binding on the single EF-hands; iii) the effect of the calcium binding to the overall protein fold. The com-
parison reveals potential surfaces of interaction between Sorcin and its targets. We further established 
consensus Sorcin-binding motifs in absence and presence of Ca2+. Finally, we validated interactions 
between Sorcin and a molecular partner endowed with such sequences, such as PDCD6 (programmed 
cell death protein 6, formerly called Alg-2), a PEF protein with similar mechanism of activation but 
different role in the cell with respect to Sorcin, through Surface Plasmon Resonance experiments and in 
the fibroblasts by co-localization experiments. Our study shed new light on the molecular basis of Sorcin 
activation, i.e. the structural changes induced by calcium binding in Sorcin, and on Sorcin mechanism of 
action, i.e. the interaction of Sorcin with its molecular partners, which leads to regulation of cytokinesis, 
to protection from apoptosis and to the establishment of MDR phenotype.
Results
Overall structures and calcium coordination. We solved structures of Sorcin in complex with 
calcium (CaSor) and in the apo form (apoSor), at a higher resolution than the one solved by Xie et al.31. 
Structures statistics are reported in Table 1. All the structures have the typical fold of the PEF proteins 
family. Briefly, the monomer is formed by two domains: a Gly-rich N-terminal domain (residues 1–32), 
partially visible in both apo and calcium-bound structures (residues 30–32 and 26–32, respectively), and 
a calcium binding domain (SCBD), containing eight α -helices (A-H) organised in five calcium binding 
motifs (EF1-EF5). Two helices are very long and connect two adjacent EF hands: the D-helix (hD) is 
common to EF2 and EF3, while the G-helix is common to EF4 and EF5 (Fig.  1). EF1 is structurally 
coupled with EF2, and EF3 is paired with EF4. Sorcin dimerization occurs by pairing of the EF5 of two 
monomers.
In CaSor, Ca2+ is bound at EF1, EF2 and EF3 and it is hepta-coordinated in a classical pentagonal 
bipyramidal configuration (Fig. 2 and Table S1). EF1 and EF2 are coupled by Gln48, which coordinates 
the EF1-bound Ca2+, whereas in EF2 is hydrogen-bound to Thr89.
Comparison of human Sorcin structures: conformational changes induced by calcium bind-
ing. The comparison between all the known human Sorcin structures (apo human Sorcin, PDB code: 
1JUO; apo-F112L human Sorcin mutant, PDB code: 2JC2; apoSor, PDB code: 4UPG; CaSor, PDB code: 
4USL) shows that the EF1–3 region is more flexible than the EF4-EF5 region and that a large conforma-
tional change in the EF1-EF2 subdomain and EF3 is visible upon calcium binding to the first three EF 
hand motifs16,31. Indeed, the rmsd values (Table S2) measured by superimposing CaSor to the apoSor 
clearly indicate that upon calcium binding Sorcin undergoes a large conformational change, mainly 
involving EF1, EF2 and EF3 (Table S2, Fig. 3). As shown in Fig. 3, calcium binding to EF1, EF2 and EF3, 
i.e. the three EF hands with the highest affinity for the cation33, induces a large displacement (of about 
21°) of the D-helix). The comparison between apoSor and the calcium-bound Sorcin structures sheds 
light on the mechanism of cation-mediated structural changes of Sorcin, which is fundamental for the 
comprehension of its function. The binding of calcium at the EF3 loop causes the movement of the three 
ligands Asp113, Asp115 and Ser117 towards the bidentate Glu124 ligand in the E-helix. Thus, the loop 
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undergoes a rearrangement and may act as a lever dragging the long and rigid D-helix away from the 
E-helix. As a result, EF3 acts as a pivot: the first half of the calcium binding domain (formed by A-, B-, 
C- and D-helices) rotates and moves away from the second half (formed by the E-, F-, G- and H-helices), 
which is the dimerization subdomain and forms the stable Sorcin dimeric interface.
Calcium binding and mechanism of activation: comparison with PDCD6 (Alg-2). Sorcin binds 
calcium at EF1, EF2 and EF3 hands. In order to investigate the role of each calcium binding site, we 
analysed each EF hand separately and evaluated the structural variation induced upon ion binding. For 




Space group I422 C2221
Cell parameters (Å) a = b = 106.4, c = 77.5 Å a = 52.4, b = 111.6, c = 60.5
Asymmetric unit (residues) Monomer (30–198) Monomer(12–17, 26–198)
N° of bound ions — 3 Ca2+
Resolution ranges (Å) 2.1–50.0 (2.1–2.2) 1.65–50 (1.65–1.69)
Unique reflections 23604 (4375) 41040 (3051)
Completness (%) 99.7 (98.2) 99.5 (99.6)
Redundancy 6.8 (7) 3.4 (3.3)
Rmerge (%) 11 (59) 4 (66)
CC(1/2) 99.8 (88.2) 99.9 (83.3)
I/σ (I) 14.8 (3.6) 21.57 (3.0)
Resolution ranges (Å) 2.10–40.59 (2.10–2.15) 1.65–37.34 (1.65–1.69)
Rcryst(%) 18.1 (23.4) 19.1 (32.9)
Rfree(%) 21.9 (30.0) 22.1 (33.3)
rms (angles) (°) 1.46 1.32
Rms (bonds) (Å) 0.01 0.01
Wilson B-factor (Å2) 29.3 21.6
Residues in core regions of the 
Ramachandran plot (%) 98.8 99.4
Residues in allowed regions of the 
Ramachandran plot (%) 1.2 0.6
Table 1.  Crystal parameters, data collection statistics and refinement statistics of Sorcin in the apo 
form (apoSor) and in complex with Ca2+ (CaSor). Values in parentheses are for the highest-resolution 
shell.
Figure 1. Overall structure of calcium-bound human Sorcin. (A) The monomer comprises a part of the 
flexible N-terminal domain containing an alpha helical region designated α 0 (red) and a calcium-binding 
domain (SCBD) that can be divided in two region: EF1-3 (blue) and EF4-5 (green). Calcium ions (yellow 
spheres) are bound at EF1, EF2 and EF3. The helices (A-H) and the EF-hands (EF1-5) are indicated. (B) 
Dimerization occurs through the pairing of EF4-5 of two monomers (cyan and magenta). The N-terminal 
hexapeptide modeled in the structure is shown as green sticks.
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the angle between the two helices of each EF-hand motif in the structures of Sorcin and of other PEF 
proteins, whereas the overall conformational change has been evaluated by measuring the variation of the 
angle between the D- and G-helices, which takes into account the movement of the EF1-EF2 sub-domain 
and EF3 with respect to the EF4 and EF5 hands (Table 2).
Figure 2. Calcium coordination in Sorcin. Close-up of Ca2+ binding sites in EF1 (A), EF2 (B) and EF3 
(C) reveals the classical pentagonal bipyramidal geometry. The involved residues are shown as sticks, water 
molecules as red spheres and calcium ions as yellow spheres. Ligand positions and coordination distances 
are listed.
Figure 3. Conformational changes induced by ion binding. The superposition of CaSor (magenta) and 
apoSor (blue) reveals the conformational variation induced by calcium (yellow spheres). The green arrows 
represent the axis of the D helix in the two structures: the binding of three Ca2+ to each Sorcin monomer 
causes a large movement of the D helix that drags the EF1-EF2 region. The panels illustrate the changes of 
EF1, EF2 and EF3 taken alone, analysed aligning the C-terminal helix for each EF-hand: EF1 and EF3 open 
upon Ca2+-binding, while EF2 is almost unchanged.
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The PEF proteins are divided in two sub-groups on the basis of the residues present on the EF1 loop; 
in the group I the EF1 loop is formed by 11 residues whereas in the group II, to which Sorcin belongs, 
the EF1 loop is formed by 12 residues35. The proteins for which both the structures in the apo form and 
in the presence of a saturating amount of calcium were determined and deposited in the PDB, have been 
chosen to be compared with Sorcin structures: human PDCD6 (PDB codes: 2ZND, 2ZN936), represent-
ative of the group I, and rat m-calpain PEF domain dVI (PDB codes: 1AJ5, 1DVI37), representative of 
the group II.
This analysis shows that in Sorcin both EF1 and EF3 hands are widely opened upon calcium binding 
(variation of the angle between the helices of the EF hand, θ = +18.4° and +14.5° respectively), while 
EF2 displays only a minimal variation (θ = − 3°).
The comparison with other PEFs is informative and interesting. PDCD6 binds Ca2+ (or Zn2+) at 
EF1, EF3 and EF5 but the local conformational changes (θ = +3.2°, + 4.8°, − 8.6°) are smaller than those 
observed in Sorcin. On the contrary calpain-dVI, which binds Ca2+ at the same sites as Sorcin (plus a 
fourth Ca2+ not bound at an EF-hand), shows a similar change for EF1 and EF3 (θ = ~20°, ~14°) and an 
evident opening of EF2 (θ = ~10°). The open question is how the local conformational changes described 
so far can be transmitted to the overall structure.
As already discussed, in Sorcin the opening of EF3 causes the exposure of a hydrophobic surface with 
the shift of the EF1-EF2 sub-domain and EF3 with respect to the EF4-EF5 sub-domain (Fig. 3). The var-
iation of the angle between D-helix and G-helix can be used as an indicator of such movement and, as 
already stated, is of about 21°. As shown by the structural analysis of CaSor the opening of EF1 causes the 
exposure of an additional hydrophobic surface. The opening of EF1 and EF3 causes the exposure of two 
distinct hydrophobic surfaces that likely mediate the interaction of Sorcin with its molecular partners.
Calcium binding to PDCD6 does not cause large conformational changes. Indeed, the superim-
position between the calcium bound and the apo PDCD6 monomers using the Cα atoms, yields a 
rmsd = 1.20 Å and the angle between the D- and G-helices varies only by 2°; the main effect is observed 
on the EF5 hand where the binding of calcium causes a slight twisting movement and opening of the 
dimer. Interestingly the hD-hG angle in both the apo and the calcium bound form of PDCD6 has a 














θ θ θ θ θ
hSorcin
 ApoSor (4UPG) 40.8° 60.7° 52° 47.3° 32.9° 57.5°
 CaSor (4USL)
59.2° 57.9° 66.5° 45.9° 29.9° 78.1°
+Ca +Ca +Ca — —
 Δ (+ Ca) +18,4° − 2.9° +14.5° − 1.40° − 3° +20.6°
hPDCD6
 PDCD6-apo (2ZND) 68.8° 51.5° 59.2° 56.5° 35.8° 80.2°
  PDCD6+ Ca (2ZN9) 
A = B
72° 52.6° 64° 58.4° 27.2° 82.2°
+Ca — +Ca — +Ca
+ 3.2° + 1.1° + 4.8° + 2.1° −8.6° +2°
  hPDCD6-Zn-Alix 
(2ZNE)
67.2 55.4 62.4 60.5 A = 31.7 B = 36.6
A = 74.5 
B = 75.4
+Zn — +Zn x2 — +Zn
 Δ(+ Zn, + pep) 
− 1.5° + 4° + 3° + 4° A = − 4° A = − 5.7°
B =  +1° B = − 4.8°
rCalpain-dVI
 apo monA (1AJ5) 40.3° 53.6° 30° 51.5° 28° 47°
 apo monB (1AJ5) 41.2° 52° (54°)* 33.6° (28.5°)* 44.5° 20.5° 48.6°
 + Ca (1DVI)
61° 63° (71°)* 46.2° (42°)* 49.4° 23.4° 52.3°
+Ca +Ca +Ca — —
 Δ (+ Ca) 
+20.7° + 9° +16° + 1.6° − 3° +5.3°
+19.7° + 11° +12° + 3° + 4° +3.7°
Table 2.  Effect of ion binding on EF-hands in PEF proteins. The angle between the helices has been 
calculated with PyMol. The angle between helices D and G is reported (θ), as an indicator of the movement 
of sub-domain EF1-EF2-EF3 with respect to EF4-EF5.
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similar target binding sites, with the difference that PDCD6 sub-domains are always in the active overall 
conformation and therefore only minor variations are necessary to allow target binding. Ca2+-dependent 
activation of PDCD6 is ascribed to the movement of the side chain of Arg125, belonging to the loop 
between EF3 and EF4, that uncovers and makes accessible the hydrophobic pocket already present in 
the apo form36.
Analysis of Sorcin solvent-accessible surface areas. The analysis of solvent accessible surface 
areas has been performed with areaimol (CCP4 suite, http://www.ccp4.ac.uk/html/areaimol.html) and 
shows that upon calcium binding there is an increase in the exposed surface areas of several residues. The 
residues with a difference in SASA (Solvent Accessible Surface Areas) higher than 30% between the apo 
and the calcium bound form of Sorcin are Tyr67, Ser80, Met81, Met86, Ile110, Arg116, Gly118, Ser143 
and Ser197 (Table S3, Fig. S1). As shown in Fig. 4A, the residues displaying the highest SASA (higher 
than 30%) are located in the loop preceding the C helix (hC), in the EF2 loop (which follows the hC), 
in the C-terminal part of the D-helix and in the EF3 loop; all these structural features present a wide 
calcium-dependent rearrangement.
Even if, as shown in Table  2, ion binding has almost no effect on the relative position of helices C 
and D of EF2 hand, upon ion binding there is a reorganization of the last part of the helix C containing 
Met81 and of the loop 83–91 containing Met86, which become exposed to the solvent. Tyr67 is placed on 
the loop between helices B and C, and in apoSor it is hydrogen bonded to Asp113 of the EF3 loop and is 
partially covered by it. Upon calcium binding this interaction is broken since Asp113 participates in ion 
coordination; the rearrangement of the EF3 loop causes also the exposure of Arg116 (Fig. 4, panel B).
We further analysed the CaSor structure using the Hotpatch server (http://hotpatch.mbi.ucla.edu/) 
in order to identify unusual hydrophobic patches likely mediating protein-protein interactions between 
Sorcin and its molecular partners38. The Hotpatch analysis highlights that besides Met86 (cyan) and 
Tyr67 (green), each Sorcin monomer has two significant regions consisting of three different zones, 
shown in Fig.  4C. The pink one includes His108 and Met132 (pocket 1), the red one Met81, Val101, 
Trp105, Val164 (pocket 2) and the orange one Ala26, Phe27, Pro28, Pro34, Leu35, Tyr36, Gly37, Tyr38, 
Ser61, Trp99 (pocket 3). Interestingly, these clusters are found in the areas most affected by calcium 
dependent structural changes, namely EF1 (orange residues) and EF3 (red and pink residues). Moreover, 
both areas include tryptophan residues (Trp99 and Trp105) strongly conserved among the PEF protein 
family members. Supporting the importance of these regions in ligands binding, Colotti and coworkers 
previously demonstrated that mutation of Trp105 impairs the capacity of Sorcin to recognize and interact 
with RyR2 and annexin 7 at physiological calcium concentrations39.
Analysis of N-terminal peptide-Sorcin interaction and comparison with the PDCD6-Alix 
structure. The analysis of the CaSor structure reveals the presence of an electron density peak in the 
cavity formed upon calcium binding and the consequent tilt of the D-helix. We fitted this electronic den-
sity map with the GYYPGG hexapeptide belonging to the N-terminal region of Sorcin (residues 12–17). 
The same region was thought to interact with PDCD6 N-terminal peptide by Jia et al.40; Suzuki et al. 
demonstrated that it probably was PEG36. We can exclude PEG binding to Sorcin structure: the Fo-Fc 
and 2Fo-Fc electron density maps shows clearly the presence of a short peptide containing side chains 
with a very well resolved proline residue clearly visible in the structure (12-GYYPGG-17; Fig.  5, Fig. 
Figure 4. Solvent accessible surface analysis and hot-spots prediction. (A) The residues that upon calcium 
binding become more accessible (SASA increase higher than 30%) are mapped as red sticks on CaSor 
structure; Tyr67 and Met86 show the strongest variation. (B) In apoSor (blue) Tyr67 forms a hydrogen bond 
with Asp113. In CaSor (magenta) the hydrogen bond is broken and the loop moves away together with helix 
B and the EF1-EF2 region. (C) Hotpatch analysis identified 3 pockets (pocket 1, magenta; pocket 2, red; 
pocket 3, orange) likely mediating protein-protein interactions.
www.nature.com/scientificreports/
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S2), belonging to a different dimer. The interacting surface between the N-terminal peptide and Sorcin 
was analysed using the program ePISA (http://www.ebi.ac.uk/msd-srv/prot_int/cgi-bin/piserver). The 
residues buried at the interface between peptide and Sorcin are: Met78, Met81, Leu82, Glu97, Ala100, 
Val101, Gly104, Trp105, His108 placed on the D helix; Phe112 on the EF3 loop; Thr131, Met132, on the 
EF4 loop; Val164, Arg167, and Asp171 on the G helix. Trp105, Glu97 and Arg167 form hydrogen bonds 
with Tyr13 and Tyr14 of the peptide (OH Tyr13-OE2 Glu97 = 2.78 Å; O Tyr13-NE1 Trp35 = 2.74 Å; O 
Tyr14-OE2 Glu97 = 2.90 Å) (Fig. 5B). The residues laying on the D helix play a major role in interacting 
with the N-terminal peptide; in particular, Trp105 establishes a strong stacking interaction with Pro15 
and is hydrogen bonded to the carbonyl group of Tyr13, determining the orientation of the peptide into 
the pocket which is opposite to that of Alix in PDCD6 (see below). These residues belong to pockets 1 
and 2, identified by Hotpatch analysis (Fig. 4C).
The calcium-dependent movements of the EF3 loop determine conformational changes of different 
extent in the PEF proteins (Fig.  S3). As shown in Table  2, the opening of D and G helices opening is 
quite similar in zinc-bound PDCD6 complexed with Alix and CaSor complexed with the N-terminal 
peptide (the measured angles between the D and G helices are 78° and 82° respectively). As described 
by Suzuki and co-workers36, the peptide binds to two juxtaposed hydrophobic pockets (1 and 2), which 
hold PPYP and YP, respectively. The residues lining the pocket 1 are Gly123, Tyr124, Arg125, Thr162, 
Phe165, Gln172, Gly174 and the residues lining the pocket 2 are Met71, Phe72, Tyr91, Asp94, Trp95, 
Phe122, Gln159. More recently a third pocket has been identified in PDCD6 (Pocket 3) capable to bind 
the type 2 motif PXPGF present in Sec31A41. Pocket 3 is formed by residues belonging to EF1, the EF1–
EF2-connecting loop, EF2, EF3 and EF4 (Phe27, Val31, Val35, Leu48, Ala51, Leu52, Ser53, Gly55, Trp57, 
Phe85, Val88, Trp89, Ile92, Thr93, Gln96, Phe99, Gly108, Met109, Phe148). Our structures obviously do 
not contain peptides bound to this pocket, but we cannot rule out the possibility of peptide binding to 
this site.
The superimposition between Alix-bound PDCD6 and CaSor clearly shows that these pockets are 
present both in both proteins, and the structural alignment reveals that many of the residues lining 
the pockets are conserved in Sorcin (underlined residues in Fig. 6D). In particular, relevant conserved 
residues are: Trp95 (Trp105, Sorcin numbering) which establishes a strong stacking interaction with the 
proline of the N-terminal peptide and in Sorcin was demonstrated to be necessary for the interaction 
with its molecular partners; Arg125 (Arg135, Sorcin numbering) whose mutation to alanine caused a loss 
of binding ability of PDCD6 to Alix; and Met71 (Met81, Sorcin numbering) which was demonstrated to 
be one of the residues changing more its SASA and that was suggested by Hotpatch analysis to be one 
of the residues mediating Sorcin interactions. A significant difference concerns Tyr91 that in Sorcin is 
substituted by Val101, allowing the interaction already described between Trp105 and Tyr13 (Figs 5B–D 
Figure 5. Interaction between Sorcin and the N-terminal peptide. (A) The electrostatic surface potential 
(blue-positive, red-negative) of CaSor dimer is shown. The hydrophobic surface corresponding to pockets 
1–2 accommodates the 12-GYYPGG-17 peptide (green) plausibly belonging to an adjacent Sorcin molecule 
in the crystal (green cartoon); the residues 11–25 are not visible (green dashes). (B) Close-up of the peptide-
binding region: the peptide is shown as green sticks, the residues interacting with the peptide are depicted 
as magenta sticks, and the hydrogen bonds between Trp105-Tyr17 and Glu97-Tyr17 are indicated as black 
dashes. (C,D) Two views of the electron density map of the peptide (2Fo-Fc, contoured at 1σ ).
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and 6B) that partially explains the opposite orientation of the N-terminal peptide in Sorcin with respect 
to Alix peptide in PDCD6.
Todd and coworkers showed that calpastatin interacts with residues belonging to A and C helices of 
the calpain-dVI in the open conformation42, corresponding to pocket 3 identified by Hotpatch analysis 
in Sorcin (data not shown). In particular two hydrophobic residues of calpastatin, namely Leu606 and 
Phe610, were found to be necessary for the interaction with calpain. The pocket where Leu606 binds is 
lined by several bulky aromatic residues (Phe99, Phe162 and Trp166) and a variety of other hydrophobic 
residues (Leu102, Leu106, Ile121 and Val125); Phe610 binds to a large hydrophobic pocket formed by the 
B helix and N-terminal part of the D helix and is in close van der Waals contact with residues His129 and 
Gln173. Two of the three aromatic residues binding calpastatin belonging to the D helix are conserved 
in Sorcin (Phe95, corresponding to Phe162 in calpain-dVI, and Trp105 corresponding to Trp166 in 
calpain-dVI), whereas the residues indicated to line the hydrophobic pocket where Leu606 of calpastatin 
binds are not conserved but anyway are substituted by hydrophobic residues (Leu106 is substituted by 
Figure 6. Peptide binding and pockets comparison in CaSor and PDCD6. (A) The superimposition of 
CaSor (magenta; calcium in yellow, peptide in green) and PDCD6 (teal; zinc in grey) in complex with Alix 
peptide (yellow) shows that the protein have a similar conformation and that both peptides bind in pocket 
2 but in opposite direction, as indicated by arrows. (B) The main residues lining pocket 2 are shown 
(Sorcin numbering); note the presence of Val101 instead of Tyr91. (C) The pockets predicted by Hotpatch 
in CaSor (left, same color code as Fig. 4C) and the pockets found in PDCD6 (right) by co-crystallization 
with Alix peptide (yellow) and Sec31A peptide (cyan) are mapped on the surfaces and indicated by 
arrows. (D) Structural alignment of Sorcin and PDCD6. The residues corresponding to the hexapeptide 
are in bold. The residues lining the pockets are colored accordingly and the ones present in both sequences 
are underlined.
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an alanine residue, Ile121 is substituted by a leucine and Val125 is substituted by a leucine). The residues 
His129 and Gln173 are not conserved in Sorcin whereas also in Sorcin the B helix and N-terminal part of 
the D helix are lined by residues forming a hydrophobic pocket, namely Phe156 (Phe224 in calpain-dVI) 
and Leu102 (substituted by Ile169 in calpain-dVI).
Phage display selection in presence of EDTA and Ca2+. To investigate if the structural changes 
conferred by the Ca2+ binding translate into specificity changes, we used Sorcin as a bait protein against 
a highly diverse M13 phage display library that displays 16mer peptides on the major coat protein p8. 
Selections were performed in the presence of EDTA (1 mM) or Ca2+ (1 mM) and were in both cases 
successful as judged by pooled phage ELISAs (i.e. signal to background > 2). Sequencing of individual 
clones (38 and 20 clones from the selections in presence or Ca2+ and EDTA, respectively) revealed that 
the majority of ligands contains a conserved Pro and that the main consensus motif under both condi-
tions is a relaxed Φ /Gly/Met-Φ /Gly/Met-x-P, where Φ /Gly/Met is an aromatic residue (Trp, Tyr or Phe) 
or a Gly or Met residue, and x is any amino acid (Fig. 7A, Fig. S4). The consensus sequence agrees with 
the GYYPG peptide belonging to the Sorcin N-terminal domain, identified in the Sorcin binding site in 
our crystal structure. In addition, there is a set of peptides that lack a clear Φ /Gly/Met-Φ /Gly/Met-x-P 
motif but instead hold an acidic-Φ motif (Fig. 7). Such peptides are more frequently observed in presence 
of Ca2+ (47% of sequenced peptides) than in the presence of EDTA (15% of sequenced peptides). In a 
cellular context, likely Sorcin can establish interactions with a variety of ligands containing the main Φ /
Gly/Met-Φ /Gly/Met-x-P motif, or the acidic-Φ motif found in intrinsically disordered regions of target 
proteins. Such interactions might be facilitated by the exposure of hydrophobic binding surface in Sorcin 
upon Ca2+ binding, as suggested by the structure. However, peptide binding might occur also in absence 
of Ca2+ if the preferred target is readily available as in the high avidity p8 phage display. Indeed, the 
presence of a high affinity ligand might shift the equilibrium towards the open conformation. Further 
detailed mechanistic studies should shed light on this issue.
Selective calcium-dependent interactions between Sorcin and targets. The interactions 
between Sorcin and PDCD6 (programmed cell death protein 6) (formerly called Alg-2) a member of 
the PEF protein family, endowed with Sorcin N-terminal consensus binding motifs was tested by both 
SPR and colocalization experiments. PDCD6 has a role in the mechanisms of apoptosis onset, and was 
shown to interact with N-terminal peptide of annexin 11 in the presence of 50 μ M Ca2+, with a higher 
affinity than Sorcin43. PDCD6 has 36% identity with respect to Sorcin, displays similar structure and 
displays residues as Trp95 Arg125 and Met71, conserved also in Sorcin, which allow its interaction with 
Alix36 and potentially with the sorcin N-terminal domain. Moreover, PDCD6 displays an N-terminal 
domain similar to that of sorcin, and containing Φ /Gly/Met-Φ /Gly/Met-x-P sequences identified as 
Sorcin-interacting motifs.
SPR experiments show that both the whole Sorcin and SCBD are able to interact with PDCD6 in 
the presence of calcium, with a KD = 3.5 μ M (Fig. 8A). In the presence of EDTA, SCBD interacts with 
PDCD6 with a KD = 5 μ M whereas the calcium-free Sorcin interacts with PDCD6 with an even lower 
affinity (KD = 12 μ M Fig. 8B). Both association and dissociation are faster in the presence of calcium than 
in the presence of EDTA. The N-terminus has therefore an inhibitory activity in Sorcin-PDCD6 inter-
action at low calcium concentrations. Additionally, both Sorcin and SCBD interact with the N-terminal 
domain of PDCD6, with KD = 5 μ M for Sorcin and KD = 6 μ M for SCBD (Fig. 8C). Partial colocalization 
Figure 7. WebLogo outputs of consensus peptide motifs identified through peptide phage display.  
(A) The Φ /Gly/Met-Φ /Gly/Met-x-P motif is based on 34 unique peptide sequences, of which 20 were 
obtained from a phage selection performed in the presence of 1 mM Ca2+. (B) The acidic-Φ motif is from 
18 unique peptides of which 16 were selected in presence of Ca2+.
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Figure 8. Interaction of Sorcin with full-length PDCD6 and N-terminus of PDCD6. (A) Sensorgrams 
showing the interaction between PDCD6, immobilized on a COOH5 chip and different concentrations of 
Sorcin (left panel; from bottom to top: 200 nM, 400 nM, 800 nM, 1.5 μ M, 3 μ M, 6 μ M), and SCBD (right 
panel; from bottom to top: 50 nM, 100 nM, 200 nM, 500 nM, 1 μ M, 2.5 μ M, 5 μ M), in the presence of 100 μ M 
calcium. (B) Sensorgrams showing the interaction between PDCD6, immobilized on a COOH5 chip and 
www.nature.com/scientificreports/
1 1Scientific RepoRts | 5:16828 | DOI: 10.1038/srep16828
Figure 9. Colocalization of Sorcin with PDCD6 and annexins 7 and 11. (A) Experiments showing 
co-localization between sorcin (rabbit α -sorcin, green) and PDCD6 (mouse α -PDCD6, red), in 3T3-L1 
preadipocytes in cytokinesis (top panel) and differentiated 3T3-L1 adipocytes (bottom panel) in X and Z 
axes. Bars: 10 μ m. Note the colocalization in the midbody of 3T3-L1 preadipocytes and in the perinuclear 
region of adipocytes. (B) Experiments showing co-localization between Sorcin (mouse α -sorcin, green) and 
annexin11 (top panel: rabbit α -annexin11, red), or annexin7 (bottom panel: rabbit α -annexin7, red), in 3T3-
L1 preadipocytes in cytokinesis. Bars: 10 μ m. Note the colocalization in the midbody (arrows and insets).
different concentrations of Sorcin (left panel: from bottom to top: 1.3 μ M, 4 μ M, 12 μ M), and SCBD (right 
panel: from bottom to top: 1.25 μ M, 2.5 μ M, 5 μ M, 10 μ M), in the presence of 1 mM EDTA. (C) Sensorgrams 
showing the interaction between the N-terminal domain of PDCD6, immobilized on a COOH5 chip and 
different concentrations of Sorcin (left panel; from bottom to top: 750 nM, 1.5 μ M, 3 μ M, 6 μ M, 12 μ M), and 
SCBD (right panel; from bottom to top: 750 nM, 1.5 μ μ M, 3 μ M, 6 μ M, 12 μ M), in the presence of 100 μ M 
calcium. (D) Scatchard plots of the experiments in Fig. 8A–C, and linear fittings. Red squares: PDCD6-
Sorcin interaction in the presence of 100 μ M calcium; red circles: PDCD6-SCBD interaction in the presence 
of 100 μ M calcium black squares: PDCD6-Sorcin interaction in the presence of 1 mM EDTA; black circles: 
PDCD6-SCBD interaction in the presence of 1 mM EDTA; red triangles: N-terminal domain of PDCD6-
Sorcin interaction in the presence of 100 μ M calcium; red crosses: N-terminal domain of PDCD6-SCBD 
interaction in the presence of 100 μ M calcium.
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between Sorcin and PDCD6 takes place in perinuclear regions of differentiated 3T3-L1 adipocytes and 
in the midbody of 3T3-L1 preadipocytes (Fig. 9A). Sorcin also colocalizes with annexin 7 and annexin 
11, which possess N-terminal domains containing Φ /Gly/Met-Φ /Gly/Met-x-P sequences, in the midbody 
of 3T3-L1 preadipocytes (Fig. 9B).
Discussion
Sorcin is overexpressed in several tumor cells as an adaptive mechanism to prevent ER stress and escape 
apoptosis triggered by chemotherapeutic agents, prompting its further investigation as a novel molecular 
target to overcome MDR26. The present study discloses the structural changes induced by calcium bind-
ing in Sorcin and sheds light on the mechanism of interaction of Sorcin with its molecular partners, and 
thereby on Sorcin-dependent regulation of cytokinesis and establishment of MDR phenotype.
The binding of calcium to Sorcin promotes a large conformational change, which involves a tilt of the 
D-helix with respect to the G-helix, with EF3 acting as a hinge (Fig. 3). This movement, as displayed in 
Table 2, is about 21° and is the highest among the PEF family members. Ca2+ binds to the three high 
affinity calcium binding sites EF1, EF2 and EF3. Calcium binding to EF1 and EF3 causes a large reor-
ganization of the EF hands and the consequent movement of the EF helices one in respect to the other, 
whereas calcium to EF2 determines only a local reorganization of the residues of the EF2 loop.
The large D-helix displacement causes the rotation of the EF1-EF2 subdomain (containing A, B, C 
and D helices) with respect to the EF3-EF4-EF5 subdomain (containing E, F, G and H helices). From 
the structure it is not possible to understand which is the calcium binding EF-hand endowed with the 
highest affinity. However, calcium binding studies performed in solution by spectroscopic methods on 
wt Sorcin and site specific mutants clearly showed that EF3 is the highest affinity site, because when 
Glu124 (the bidentate ligand in EF3) is mutated the affinity for calcium of the entire protein dramat-
ically decreases33. Mutation in the bidentate Glu94 or Glu53 (placed on the EF2 and EF1 loops) has 
milder effects on overall Sorcin calcium affinity and on Sorcin ability of interacting with target proteins. 
The superimposition (Fig.  3) between the CaSor and apoSor shed light on the mechanism of Sorcin 
activation induced by the calcium binding to EF3: the binding of the cation promotes the movement 
of three calcium ligands (Asp113, Asp115 and Ser117) towards the E-helix where Glu124, the bidentate 
ligand (Fig. 3), is located and consequently, a large movement of the D helix with respect to the E helix 
(about 15°, see Table 2). This movement is transmitted to the EF1-EF2 subdomain via the Tyr 67 placed 
in a strategic position, in the middle of the loop connecting EF1 to EF2, and anchoring the EF1-EF2 
subdomain to the EF3 loop. The binding of calcium to EF3 causes the breakage of the hydrogen bond 
between Asp113 (one of the calcium ligands of EF3) and Tyr67 and consequently the hC and hB helices 
are free to move.
The structural analysis shows that upon calcium binding there is the formation of two possible inter-
action sites per monomer. A site (pocket 1 + 2 in the Hotpatch analysis) is lined by residues of the 
C-terminal part of the D helix and residues of the EF3-hand, which in PDCD6 is the site of interaction 
with Alix. Another potential site (pocket 3 in the Hotpatch analysis) involves the EF1 and EF2, which 
in calpain-dVI bind calpastatin and in PDCD6 binds Sec31A41,42. Interestingly, the interaction with a 
N-terminal peptide is similar to that of the peptide bound by PDCD6, and the stacking interaction with 
the proline of the peptide and Trp105 is conserved between the two structures. It confirms that Trp105 
is a residue with a key role in the recognition of hydrophobic Pro-containing peptides in both PEF 
proteins. The peptide phage display experiments confirm that Sorcin binds preferentially Pro-containing 
peptides. This analysis further suggests an alternative binding motif (acidic-Φ ). The interaction with 
the latter motif appears to be promoted by calcium binding. Positively charged residues located in the 
EF-loop (Arg135) and at the G-helix (Arg174, Arg175, Arg176), close to pocket 2, or His108 in pocket 
1 are possibly responsible for the binding of these peptides.
Thus, Sorcin may interact via both its N-terminal domain and its SCBD domain with proteins contain-
ing the Φ /Gly/Met-Φ /Gly/Met-x-P consensus motif, such as TRAP1, a global regulator of tumor metabolic 
reprogramming44, which contains a SIFYVPDMKP sequence that includes the consensus motif. In this 
framework, the SPR experiments carried out to study the interaction of Sorcin and SCBD with PDCD6 
demonstrates that the interaction takes place via sorcin C-terminal domain, because SCBD retains the 
ability to interact with the target. Moreover, the SPR experiments show that the affinity between SCBD 
and PDCD6 is higher than between PDCD6 and Sorcin, demonstrating that the N-terminal domain 
partially inhibits this interaction at low, physiological calcium concentration (in the presence of EDTA). 
These data shed light on the possible role of different splicing version of Sorcin, which mostly differ for 
the length of their N-terminus, and can interact in different fashion with different targets: the short, 
so called mitochondrial 19-kDa Sorcin B-isoform lacks the residues 2–17 (AYPGHPGAGGGYYPGG), 
which include the region that, in the crystal structure, interacts with the hydrophobic calcium-dependent 
pocket 1. The Sorcin B-isoform may therefore able to interact with targets with higher affinity than the 
A-isoform. The interaction of the N-terminal domain with the C-terminal domain of a neighbouring 
dimer may also be responsible for Sorcin oligomerization (Fig. 6).
Partial colocalization between Sorcin and PDCD6 takes place in perinuclear regions of differentiated 
3T3-L1 adipocytes and in the midbody of 3T3-L1 preadipocytes (Fig. 9). This interaction may be impor-
tant for the formation of this transient structure in the latest stage of cytokinesis. A competition between 
Sorcin and PDCD6 for similar targets may also take place, via pockets exposed to solvent upon calcium 
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binding. Interestingly PDCD6 has a mechanism of activation based on the switch of an arginine residue 
and this residue is conserved also in sorcin (Arg135, Sorcin numbering)36. Calcium-dependent inter-
actions with annexin 7 and annexin 11 in the midbody may also take place with the same mechanism.
In conclusion, in this paper the Ca2+-induced conformational change in sorcin has been investigated 
for the first time. We demonstrate that this change involves a large movement of the D-helix, which 
takes place in this extent only in sorcin among PEF proteins. Moreover, the study reported here gives 
the unique opportunity to visualize the interaction between the two sorcin domains: SCBD and the 
N-terminal domain. Finally, we demonstrate that the interaction between sorcin and its molecular part-
ners may take place via both the SCBD and N-terminal domain and that this latter domain may exert a 
regulative role by inhibiting in some extent the binding of sorcin to its protein targets.
Methods
Protein crystallization, data collection and data reduction. Recombinant proteins (human 
Sorcin, SCBD and PDCD6) were expressed in pET vectors (Novagen) in E. coli BL21(DE3) cells, purified 
according to published procedures18 and dialysed in 20 mM Tris-HCl, at pH 7.5. Automated crystalliza-
tion screening and by-hand optimization were carried out at 298 K by the hanging-drop vapor diffusion 
method. Since sorcin precipitates when it is saturated with calcium, we performed the starting crystalliza-
tion trials with commercial screens adding 5 mM CaCl2 in the reservoir before mixing the crystallization 
drops. ApoSor resulted to be rather prone to crystallization even in the presence of calcium; therefore, 
in order to discriminate between apoSor and CaSor crystals we performed all the crystallization trials 
in double, with and without calcium. The apoSor crystallization trials were performed using a protein 
sample concentrated to about 10 mg/ml. Aliquots (1 μ l) of the protein sample were mixed with an equal 
amount of reservoir solution containing 20–22% (w/v) polyethylene glycol 4000, 0.3–0.5 M ammonium 
sulfate. Crystals grew in 2 weeks and reached dimensions of 0.1 mm × 0.2 mm × 0.3 mm.
Crystals of CaSor were obtained by mixing 1 μ l of protein solution, concentrated to about 15 mg/
ml, using a reservoir solution containing: 20–25% (w/v) polyethylene glycol 3350, 0.5 M lithium sulfate, 
0.1 M Tris-HCl at pH = 8.5 and 5 mM CaCl2. For data collection, apoSor and CaSor were cryo-protected 
in a solution containing 80% (v/v) of mother liquor and 20% (v/v) polyethylene glycol 200. The crystals 
were mounted in nylon loops and flash frozen by quick submersion into liquid nitrogen and transported 
to the synchrotron-radiation source. Single-wavelength data sets (λ = 1 Å) were collected from crystals 
of apoSor and CaSor at the 5.2 R beamline of the Synchrotron Radiation Source ELETTRA (Trieste, 
Italy), using a Pilatus 2 M detector at a temperature of 100 K. The data sets were processed with XDS45 
and scaled with XSCALE45. Crystal parameters and data collection statistics for the measured crystals 
are listed in Table 1.
Structure solution and refinement. The structure of apoSor was determined by molecular replace-
ment with the program MOLREP46 (CCP4 suite) using the structure of the calcium-free human Sorcin 
(PDB entry 1JUO)31 as search model.
The case of CaSor was more complex: first we solved the structure of SCBD (Sorcin Calcium Binding 
Domain) with calcium (Ca-SCBD, data not shown), using the structure of the calcium-free human 
Sorcin; then we used SCBD monomer to solve CaSor. Ca-SCBD crystallized in orthorhombic space 
group and the Matthews coefficient calculation indicated a dimeric asymmetric unit. The first attempts 
to solve the phase problem for Ca-SCBD using the whole apo-Sorcin dimer were unsuccessful, suggest-
ing a wide conformational variation. Based on previous published results we expected that the variation 
regarded mainly the EF1–2–3 subdomain. For this reason we performed the rotational and translational 
searches with a truncated apo-dimer including E-F-G-H helices (EF4–5 plus part of EF3), finding a 
partial solution. We fixed this solution and repeated the search using the rest of the apo-model (helices 
A, B, C, D). Refinements were performed using the maximum-likelihood method with the program 
REFMAC47 and model building with the program Coot48. The quality of the models was assessed using 
the program PROCHECK49. The structure of apoSor was refined to 2.1 Å resolution. The final model 
contains 168 residues (residues 30–198), 73 water molecules, 5 sulfate ions. The structure of CaSor was 
refined to 1.65 Å resolution. The final model contains 172 residues (residues 26–198), a six residues long 
peptide, 124 water molecules, 1 sulfate ion, 3 Ca(II) ions with full occupancy and 3 PEG molecules for 
each monomer.
PDB accession codes. The coordinates for apoSor have been deposited in the Research Collaboratory 
for Structural Bioinformatics (RCSB) PDB with accession code 4UPG. The coordinates for CaSor have 
been deposited in the RCSB PDB with accession code 4USL.
Phage Display. We used a phage library displaying 16mer randomized peptides (diversity 4 × 1010) 
on the p8 protein flanked by spacer linkers at the N- and C- termini (SSSG- and GGGSGG, respectively). 
The library is similar to the previously established C-terminal library50, but displaying internal, instead of 
C-terminal, peptide stretches. Phage selections were performed in 5 rounds following the detailed pro-
tocols in ref. 51. To assess a potential calcium dependence of the interactions selections were performed 
in parallel using either 1 mM EDTA or 1 mM CaCl2 during the incubation of the phage library with the 
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bait protein as well as in all washing steps. Such an approach has previously been successfully used for 
the identification of calcium-dependent interactions for the calcium-binding protein S100B52. Clonal 
analysis and sequencing was performed as previously described53.
Cell cultures. Mouse 3T3-L1 preadipocyes (ATCCR CL-173TM, American Type Culture Collection) 
and 3T3-L1 adipocytes were grown on plastic dishes or 10-mm glass coverslips using Dulbecco’s modi-
fied Eagle’s medium supplemented with 10% calf serum, 4 mM glutamine, 50 mg/l streptomycin, 100 IU/l 
penicillin and non-essential amino acids at 37 °C in a humidified CO2 incubator. 3T3-L1 preadipocytes 
were differentiated into adipocytes as described by Tafuri, adding 7.5 μ M troglitazone in the medium on 
days 3 and 4 of differentiation54.
The mouse α -Sorcin (33–800) was from Zymed, the rabbit α -Sorcin was homemade, the rabbit 
α -annexin 11 (NB100–78588) was from Novus Biologicals, the rabbit α -annexin 7 (ABIN65268) and 
the mouse α -PDCD6 (H00010016-M01) were from Abnova.
For immunofluorescence staining, cells were plated and grown on 10 mm glass coverslips, fixed with 
2% paraformaldehyde for 20 min, permeabilized with 0.2% Triton X-100 for 10 min and incubated in 
50 mM glycine for 30 min more. Primary antibody dissolved in 1% bovine serum albumin was added 
and allowed to incubate overnight at 4 °C. Primary antibody was removed, wells washed and second-
ary AlexaFluor 488, 594 or 647 was added and incubated for 1 h at room temperature. Conventional 
immunofluorescence and confocal microscopy were performed using confocal LSM710 vertical and 
Axiovert135M microscope (Zeiss).
Surface Plasmon Resonance experiments. Surface Plasmon Resonance (SPR) experiments were 
carried out using a SensiQ Pioneer system. The sensor chip (COOH5) was activated chemically by a 
35 μ l injection of a 1:1 mixture of N-ethyl-N′ -(3-(diethylaminopropyl)carbodiimide (200 mM) and 
N-hydroxysuccinimide (50 mM) at a flow rate of 5 μ l/min. Ligands, i.e. PDCD6 and the N-terminal 
domain of PDCD6 (KMAAYSYRPGPGAGPGPAAGAALP; a lysine residue has been added to the 
sequence to ensure peptide immobilization principally via the N-terminus), were immobilized on acti-
vated sensor chips via amine coupling. The immobilizations were carried out in 20 mM sodium acetate 
at pH 4.5; the remaining ester groups were blocked by injecting 1 M ethanolamine hydrochloride (35 μ l). 
Proteins interacting with the ligands (in 10 mM Hepes pH 7.4, 150 mM NaCl + 0.005% surfactant P20) 
were injected on the sensor chip at a constant flow (30 μ l/min). The same procedure was set using the 
buffer with CaCl2 at 100 μ M concentration, or with 1 mM EDTA. The increase in RU relative to baseline 
indicates complex formation; the plateau region represents the steady-state phase of the interaction, 
whereas the decrease in RU represents dissociation of Sorcin or SCBD from immobilized ligands after 
injection of buffer. Regeneration procedures are based on two long (2000 s and 500 s) injections of buffer, 
separated by a brief (5 s) injection of 10 mM NaOH. The sensorgrams were analysed using the SensiQ 
Qdat program.
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